RP-HPLC法测定糖尿病患者红细胞膜磷脂酰胆碱含量(2)
| 第1页 |
参见附件。
参 考 文 献
[1] 杨金奎.糖尿病并发症发病机制新认识.国际内分泌代谢杂志,2008,28(1):18-21.
[2] WHO Multinational Study Group.The WHO multinational study of vascular disease in diabetes.Diabetes Res Clin Pract,2002,56:S6.
[3] 邓华聪,邱鸿鑫,汪恕萍,等,糖尿病患者红细胞膜磷脂成分改变与脂质过氧化视网膜病变的关系.中华内科杂志,1994,33(12):833-834.
[4] MellitusSetter et al.Biochemical Pathways for Microvascular Complications of Diabetes Ann Pharmacother,2003,37:1858-1866.
[5] 崔莹.磷脂的高效液相色谱分析.福建分析测试,2007,16(1):71-74.
[6] Caimi G, P resti L P,Montana M , et al.Platelet membrane fluidity, platelet membrane lipid pattern and platelet cyto solic Ca2+ content in subuects with vascular atheo sclerotic disease.Clin Hemorheol,1994,14 (3):393.
[7] Higgins JA.Seperation and analysis of membrane lipid components.In:Findlay JBC, ed.Biological membrane a partical approach.Oxford:IRL press,1987:103-106.
[8] 李红.糖尿病微血管病变发病机制和治疗靶点.浙江大学学报,2006,35(3):233-237.
[9] Jenkins, A.J.1; Rowley, K.G.1,et al.Poproteins and Diabetic Microvascular Complications.J Current Pharmaceutical Design, 2004,10(27):3395-3418.
您现在查看是摘要介绍页，详见PDF附件。